Delivery Order SPE2DB22D1200-SPE2DB24FN3EE

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,231.36 firm fixed-price delivery order is for the supply of 4,567,102,514 units of Menopur 75 unit vials. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,804.77, is for the delivery of 4,566,929,731 units of MENOPUR 75 UNIT VIALS. This is a firm fixed-price delivery order contract with a completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,567,128,678 units of the pharmaceutical product Menopur 75 unit vials, with a total ceiling value of $57,087.30 and a period of performance through February 4, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $78,983.74 Firm Fixed Price delivery order is for the supply of MENOPUR 75 UNIT VIALS medical products. The contract has an ultimate completion date of March 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $137,960.35, is a Delivery Order for the procurement of 4,567,754,856 units of MENOPUR 75 UNIT VIALS. The contract has a Firm Fixed Price pricing type and an ultimate completion date of April 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of MENOPUR 75 unit vials to the Defense Logistics Agency (DLA). The contract, awarded to AmerisourceBergen Drug Corporation, is a Firm Fixed Price Delivery Order valued at $19,597.26 and has an ultimate completion date of July 9, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,229.63 firm fixed-price delivery order contract is for the supply of MENOPUR 75 unit vials, a specialty medication. The contract has a period of performance through May 15, 2024 and was awarded on May 14, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,258.00 firm fixed-price delivery order is for the supply of MENOPUR 75 UNIT VIALS, a pharmaceutical product, with a period of performance through February 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) on July 2, 2024 for the delivery of 4,565,058,855 units of MENOPUR 75 UNIT VIALS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $73,941.66 and an ultimate completion date of July 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of MENOPUR 75 unit vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,767.32 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 20, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB24FN3EE
    Delivery Order

This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award, with a ceiling value of $16,197.48, is for the delivery of Menopur 75 unit vials, a specialty medication. The contract is a Firm Fixed Price Delivery Order, with a period of performance through June 2024.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:58 AM